[go: up one dir, main page]

HK1014941B - New manufacturing process - Google Patents

New manufacturing process Download PDF

Info

Publication number
HK1014941B
HK1014941B HK99100002.8A HK99100002A HK1014941B HK 1014941 B HK1014941 B HK 1014941B HK 99100002 A HK99100002 A HK 99100002A HK 1014941 B HK1014941 B HK 1014941B
Authority
HK
Hong Kong
Prior art keywords
ethyl
dichlorobenzylidene
felodipine
ethanol
aminocrotonate
Prior art date
Application number
HK99100002.8A
Other languages
German (de)
French (fr)
Chinese (zh)
Other versions
HK1014941A1 (en
Inventor
Gustavsson Anders
Kallstrom Ake
Palmer Sven
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600086A external-priority patent/SE9600086D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1014941A1 publication Critical patent/HK1014941A1/en
Publication of HK1014941B publication Critical patent/HK1014941B/en

Links

Description

Field of the invention
The present invention relates to an improved method for the manufacture of felodipine (ethyl methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine-dicarboxylate) via the route of reacting 2,3-dichlorobenzylideneacetylacetic acid-methylester (in the following dichlorobenzylidene for short) with ethyl 3-aminocrotonate.
Prior art
EP 7293 discloses a method for the preparation of felodipine using dichlorobenzylidene and ethyl 3-aminocrotonate as starting materials. The solvent used is tertiary butanol. No catalyst is used. The reaction time is long.
US 5 310 917 discloses a method for the preparation of felodipine using dichlorobenzylidene and ethyl 3-aminocrotonate as starting materials. The solvent used is ethanol.
Disclosure of the invention
It has now been found that felodipine can be prepared in a manner that is fast, environmentally sound and gives a good yield using starting materials that are known per se. The new method uses pyridine in catalytic amounts in combination with ethanol as solvent.
Specifically, the present invention relates to an improved method for the manufacture of felodipine characterized by reacting 2,3-dichlorobenzylideneacetylacetic acid-methylester with ethyl 3-aminocrotonate in refluxing alcohol in the presence of pyridine as catalyst and purifying the obtained felodipine by crystallization from acetone.
The method is described by the reaction scheme below:
Dichlorobenzylidene is reacted with ethyl 3-aminocrotonate in the presence of pyridine in refluxing ethanol. Ethanol is evaporated at reduced pressure and ethyl acetate or methylene chloride is added. The solution is purified by acidic and neutral aqueous extractions. The solvent is removed by evaporation. The product is dissolved in acetone, crystallized by cooling, isolated by filtration and finally washed with acetone.
Dichlorobenzylidene is reacted with ethyl 3-aminocrotonate (0.5-0.9 g/g dichlorobenzylidene, preferably 0.58-0.60 g/g dichlorobenzylidene). The reactants are charged together with the solvent ethanol (2.5-4.8 ml/g, preferably 3.2-3.9 ml/g dichlorobenzylidene) and the catalyst pyridine (0.03-0.2 ml/g dichlorobenzylidene, preferably 0.035-0.045 g/g dichlorobenzylidene).
Preparation of dichlorobenzylidene starting material
2,3-Dichlorobenzaldehyde is reacted with methyl acetoacetate in a suitable solvent in the presence of a catalytic amount of acetic acid and piperidine. Water is azeotropically separated off during the reaction. The reaction mixture is extracted in order to remove the catalysts. The solvent is evaporated and methanol is added. The product is crystallized by cooling the solution, isolated by filtration and finally washed with methanol.
Working examples Example 1
35.3 g of dichlorobenzylidene was reacted with 20.7 g of ethyl 3-aminocrotonate in the presence of 1.3 g of pyridine in refluxing ethanol (91 ml). Ethanol was evaporated under reduced pressure and ethyl acetate (195 ml) was added in order to dissolve the residue. The solution was purified by acidic extraction (7.3 g of (HCl (aqeous) in 30 ml of H2O). The solvent was evaporated and acetone (116 ml) was added. The product was crystallized by cooling the solution to -10°C, isolated by filtration and washed with acetone. Yield: Approximately 85%
Reference example
30.3 g of dichlorobenzylidene was reacted with 17.8 g of ethyl 3-aminocrotonate in the presence of 5.9 g of pyridine in refluxing ethanol (94 ml). Ethanol was evaporated under reduced pressure and 118 ml of methylene chloride was added. The solution was purified by acidic extraction (6.3 g of HCl (aqeous) in 24 ml of H2O). The methylene chloride phase was treated with 3 g of sodium sulphate (anhydrous) in order to remove the residues of water. The solvent was evaporated and 85 ml of diisopropyl ether was added. The product was crystallized by cooling the solution to 0°C, isolated by filtration and washed with diisopropyl ether. Yield: Approximately 85%

Claims (8)

  1. A method for the manufacture of felodipine, characterized by reacting 2,3-dichlorobenzylideneacetylacetic acid-methylester with ethyl 3-aminocrotonate in refluxing alcohol in the presence of pyridine as catalyst and purifying the obtained felodipine by crystallization from acetone.
  2. A method according to claim 1 wherein the alcohol is ethanol.
  3. A method according to claims 1-2 wherein the obtained felodipine is taken up into a solution.
  4. A method according to claim 3 wherein the obtained felodipine is taken up into ethyl acetate.
  5. A method according to claim 3 wherein the obtained felodipine is taken up into methylene chloride.
  6. A method according to any of the preceding claims, wherein the amount of ethyl 3-aminocrotonate is 0.5-0.9 g per g of 2,3-dichlorobenzylideneacetylacetic acid-methylester.
  7. A method according to any of the preceding claims, wherein the amount of ethanol is 2.5-4.8 ml per g of 2,3-dichlorobenzylideneacetylacetic acid-methylester.
  8. A method according to any of the preceding claims, wherein the amount of pyridine is 0.03-0.2 ml per g of 2,3-dichlorobenzylideneacetylacetic acid-methylester.
HK99100002.8A 1996-01-10 1996-12-13 New manufacturing process HK1014941B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9600086 1996-01-10
SE9600086A SE9600086D0 (en) 1996-01-10 1996-01-10 New manufacturing process
PCT/SE1996/001649 WO1997025313A1 (en) 1996-01-10 1996-12-13 New manufacturing process

Publications (2)

Publication Number Publication Date
HK1014941A1 HK1014941A1 (en) 1999-10-08
HK1014941B true HK1014941B (en) 2003-11-28

Family

ID=

Similar Documents

Publication Publication Date Title
EP0874822B1 (en) New manufacturing process
RU2163597C2 (en) Method of synthesis of 3-ethyl-5-methyl-2-(2-aminoethoxymethyl)- -4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridine dicarbo-xylate and benzenesulfoacid salt (amlodipine bezylate)
AU759211B2 (en) New manufacturing process
HK1014941B (en) New manufacturing process
EP0371492B1 (en) Process for the preparation of 1,4-dihydropyridine derivatives
JP2010065051A (en) Process for producing nifedipine
EP1532110B1 (en) Industrial process for the synthesis of isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridine dicarboxylate (nisoldipine)
EP2114883A1 (en) Process for preparing lercanidipine hydrochloride
JP5463051B2 (en) Method for producing 1,4-dihydropyridine derivative
US7329756B2 (en) Process for the manufacture of Isradipine
JP2000515855A (en) Method for producing dihydropyridines
KR900002053B1 (en) Process for preparing alpha-aryl-4-substituted piperidine alkanol derivatives
WO2005023768A1 (en) An improved process for the preparation of pure nisoldipine
JPH08217749A (en) New production of nicardipine hydrochloride and new synthetic intermediate
IE80422B1 (en) Novel process for producing nicardipine hydrochloride and its novel intermediate compound
WO2007131759A1 (en) A process for the preparation of amlodipine benzenesulfonate